Evolving concepts in the management of lobular neoplasia.

作者: Benjamin O. Anderson , Kristine E. Calhoun , Eric L. Rosen

DOI: 10.6004/JNCCN.2006.0041

关键词:

摘要: Lobular neoplasia broadly defines the spectrum of changes within lobule, ranging from atypical lobular hyperplasia (ALH) to carcinoma in situ (LCIS). This continuum lesions is associated with an increased risk for developing subsequent invasive breast cancer, magnitude that corresponding degree proliferative change. The cancer after a diagnosis multicentric, bilateral, and equal both breasts. itself may transform into carcinoma, although frequency this occurrence unknown. Thus, factor be precursor lesion unusual circumstances. management ALH LCIS depends on setting which they are encountered. When diagnosed core needle biopsy, wire localization surgical excision required definitive because rates histologic underestimation approach those ductal (ADH). generally do not require further intervention, even when present at margin. However, bilateral must considered, especially patients have family history cancer. In selected situations, prophylactic mastectomy or without reconstruction considered diagnosed. Although reduces by 90%, represent small subgroup other factors, such as strong evidence genetic predisposition.

参考文章(62)
F. W. Foote, F. W. Stewart, Lobular carcinoma in situ: A rare form of mammary cancer. CA: A Cancer Journal for Clinicians. ,vol. 32, pp. 234- 237 ,(1982) , 10.3322/CANJCLIN.32.4.234
Strumane K, Cornelisse C, Nollet F, Cleton-Jansen Am, Berx G, van Roy F, de Leeuw Wj, E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. ,vol. 13, pp. 1919- 1925 ,(1996)
C Gamallo, P Navarro, A Suarez, A Cano, M Quintanilla, J Palacios, A Pizarro, Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. American Journal of Pathology. ,vol. 142, pp. 987- 993 ,(1993)
Vincenzo Eusebi, Christine Betts, Darrow E. Haagensen, Patrizia Gugliotta, Gianni Bussolati, John G. Azzopardi, Apocrine differentiation in lobular carcinoma of the breast: A morphologic, immunologic, and ultrastructural study Human Pathology. ,vol. 15, pp. 134- 140 ,(1984) , 10.1016/S0046-8177(84)80053-2
W Birchmeier, U H Frixen, R Moll, M Mitze, Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. American Journal of Pathology. ,vol. 143, pp. 1731- 1742 ,(1993)
Trevor Powles, Ros Eeles, Sue Ashley, Doug Easton, Jenny Chang, Mitch Dowsett, Alwynne Tidy, Jenny Viggers, Jane Davey, Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial The Lancet. ,vol. 352, pp. 98- 101 ,(1998) , 10.1016/S0140-6736(98)85012-5
Masahiro Kashiwaba, Gen Tamura, Yasushi Suzuki, Chihaya Maesawa, Satoshi Ogasawara, Ken Sakata, Ryoichi Satodate, Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Japanese Journal of Cancer Research. ,vol. 86, pp. 1054- 1059 ,(1995) , 10.1111/J.1349-7006.1995.TB03020.X
Noel Weidner, Joseph P. Semple, Pleomorphic variant of invasive lobular carcinoma of the breast. Human Pathology. ,vol. 23, pp. 1167- 1171 ,(1992) , 10.1016/0046-8177(92)90035-2
Vincenzo Eusebi, Fatima Magalhaes, John G. Azzopardi, Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Human Pathology. ,vol. 23, pp. 655- 662 ,(1992) , 10.1016/0046-8177(92)90321-S
C. D. Haagensen, Nathan Lane, Raffaele Lattes, Carol Bodian, Lobular neoplasia (so-called lobular carcinoma in situ) of the breast Cancer. ,vol. 42, pp. 737- 769 ,(1978) , 10.1002/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T